Myelodysplastic Syndromes—A Population-Based Study on Transformation and Survival

References

• Galton D AG. The myelodysplastic syndromes. Scand J Haematol 1986; 36(11(Suppl 45))11–20
   PubMedGoogle Scholar
• Bennett J M, Catovsky D, Daniel M T. Proposal for the classification of the myelodysplastic syndromes. Br J Haematol 1982; 51: 189–98
   PubMed Web of Science ®Google Scholar
• Foucar K, Langdon R M, Armitage J O, Olson D B, Caroll T J. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases. Cancer 1985; 56: 553–61
   PubMed Web of Science ®Google Scholar
• May S J, Smith S A, Jacobs A, Williams A, Bailey-Wood R. The myelodysplastic syndrome: Analysis of laboratory characteristics in relation to the FAB classification. Br J Haematol 1985; 59: 311–9
   PubMed Web of Science ®Google Scholar
• Tricot G, Vlietninck R, Verwilghen R L. Prognostic factors in the myelodysplastic syndromes. A review. Scand J Haematol 1986; 36((Suppl 45))107–13
   PubMedGoogle Scholar
• Sanz G F, Sanz M A, Vallespi T, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes. A multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74: 395–408
   PubMed Web of Science ®Google Scholar
• Sutton L, Leblond Le V., Maignan C, et al. Bone marrow transplantation for myelodysplastic syndrome and secondary leukemia: outcome in 86 patients. Bone Marrow Transplant 1991; 7((Suppl 2))39
   PubMedGoogle Scholar
• Ganser A, Hoelzer D. Clinical course of myelodysplastic syndromes. Hematol Oncol Clin North Am 1992; 6: 607–18
   PubMed Web of Science ®Google Scholar
• Aul C, Schneider W. Myelodysplastic syndromes. A prognostic factor analysis of 221 untreated patients. Blut 1988; 57: 234–42
   Google Scholar
• Mufti G J, Stevens J R, Oscier D G, et al. Myelodysplastic syndromes. A scoring system with prognostic significance. Br J Haematol 1985; 59: 425–33
   PubMed Web of Science ®Google Scholar
• Teerenhovi L, Lintula R. Natural course of myelodysplastic syndromes—Helsinki experiences. Scand J Haematol 1986; 36((Suppl 45))102–6
   Google Scholar
• Vallespi M T, Torrabadello M, Julia A, et al. Myelodysplastic syndromes: A study of 101 cases according to the FAB classification. Br J Haematol 1985; 61: 83–92
   PubMed Web of Science ®Google Scholar
• Second international workshop on chromosomes in leukemia: Chromosomes in preleukemia. Cancer Genet Cytogenet 1980; 2: 108–13
   Google Scholar
• Nowell P C. Cytogenetics of preleukemia. Cancer Genet Cytogenet 1982; 5: 265–78
   PubMed Web of Science ®Google Scholar
• Knapp R H, Dewald G W, Pierre R V. Cytogenetic studies in 174 consecutive patients with preleukemic or myelodysplastic syndromes. Mayo Clin Proc 1985; 60: 507–16
   PubMed Web of Science ®Google Scholar
• Jacobs R H, Cornbleet M A, Vardiman J W, et al. Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes. Blood 1986; 67: 1765–72
   PubMed Web of Science ®Google Scholar
• Pierre R V, Catovsky D, Mufti G J, et al. Clinical-cytogentic correlations in myelodysplasia (preleukemia). Cancer Genet Cytogenet 1989; 40: 149–61
   PubMed Web of Science ®Google Scholar
• Armitage J O, Dick F R, Needleman S W, et al. Effect of chemotherapy for the dysmyelopoietic syndrome. Cancer Treat Rep 1981; 65: 601–5
   PubMedGoogle Scholar
• Fenaux P, Morel P, Rose C, et al. Prognostic factors in de novo myelodysplastic syndromes treated by intensive chemotherapy. Br J Haematol 1991; 77: 497–501
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M-T, et al. Proposals for the classification of the acute leukaemias. Br J Haemat 1976; 33: 451–8
   PubMed Web of Science ®Google Scholar
• Bennett J M, Catovsky D, Daniel M T, et al. Criteria for the diagnosis of acute myelogenous leukemia of megakaryocytic lineage (M7). Ann Intern Med 1985; 103: 460–2
   PubMed Web of Science ®Google Scholar
• Peto R, Pike M C, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. Analysis and examples. Br J Cancer 1977; 35: 1–39
   PubMed Web of Science ®Google Scholar
• Linman J W, Bagby G C. The preleukemic syndrome (hematopoietic dysplasia). Cancer 1978; 42: 852–64
   Web of Science ®Google Scholar
• Weber R FA, Geraedts J PM, Kerkhofs H, et al. The preleukemic syndrome. I. Clinical and hematological findings. Acta Med Scand 1980; 207: 391–5
   PubMed Web of Science ®Google Scholar
• Jacobs A, Clark R E. Pathogenesis and clinical variations in the myelodysplastic syndromes. Clin Hematol 1986; 15: 925–51
   PubMedGoogle Scholar
• Sanz G F, Sanz M A, Vallespi T, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes. A multivariate analysis of prognostic factors in 370 patients. Blood 1989; 74: 395–408
   PubMed Web of Science ®Google Scholar
• Hoelzer D, Ganser A, Heimpel H. ‘Atypical’ leukemias; Preleukemia, smouldering leukemia and hypoplastic leukemia. Recent Results Cancer Res 1984; 93: 69–101
   PubMedGoogle Scholar
• Kantarjian H M, Keating M J, Walters R S, et al. Therapy-related leukemia and myelodysplastic syndrome: Clinical, cytogenetic and prognostic features. J Clin Oncol 1986; 4: 1748–57
   PubMed Web of Science ®Google Scholar
• DeWitte T, Muus P, De Pauw B, et al. Intensive antileukemic treatment of patients younger than 65 years with myelodysplastic syndromes and secondary acute myelogenous leukemia. Cancer 1990; 66: 831–7
   PubMed Web of Science ®Google Scholar
• Michels S D, Saumur J, Arthur D C, et al. Refractory anemia with excess of blasts in transformation. Hematologic and clinical study of 52 patients. Cancer 1989; 64: 2340–6
   PubMed Web of Science ®Google Scholar
• Tricot G, Boogaerts M A. The role of aggressive chemotherapy in the treatment of myelodysplastic syndromes. Br J Haematol 1986; 63: 477–83
   PubMed Web of Science ®Google Scholar
• DeWitte T, Zwaan F, Hermans J, et al. Allogeneic bone marrow transplantation for secondary leukemia and myelodysplastic syndrome: A survey by the leukemia working party of the European bone marrow transplantation group (EBMTG). Br J Haematol 1990; 74: 151–5
   PubMed Web of Science ®Google Scholar
• Appelbaum F R, Barell J, Storb R, et al. Bone marrow transplantation for patients with myelodysplastia. Ann Intern Med 1990; 112: 590–7
   PubMed Web of Science ®Google Scholar
• Belanger R, Gyger M, Perrault C, et al. Bone marrow transplantation for myelodysplastic syndromes. Br J Haematol 1988; 69: 29–33
   PubMed Web of Science ®Google Scholar